{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-053522","form_type":"8-K","ticker":"ANGO","cik":"0001275187","company_name":"ANGIODYNAMICS INC","filed_at":"2023-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.502556+00:00","generated_at":"2026-06-08T00:55:21.919753+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"AngioDynamics shareholders approve amended equity plan and elect directors at annual meeting","bullets":["All four board nominees elected with votes ranging from 23.6M to 25.9M for; avg 24.7M for, 1.9M withheld.","Amended 2020 Equity Incentive Plan approved with 24.1M for and 2.5M against (excl. 5.8M broker non-votes).","Advisory say-on-pay approved with 24.4M for, 2.2M against; annual frequency vote also passed.","Ratification of Deloitte & Touche as auditor for FY ending May 31, 2024: 32.4M for, 11K against.","Company will hold advisory say-on-pay votes annually until next required frequency vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-053522","json":"https://secwatch.observer/filing/0001140361-23-053522.json","markdown":"https://secwatch.observer/filing/0001140361-23-053522.md","text":"https://secwatch.observer/filing/0001140361-23-053522.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/ef20014806_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T00:55:21.919753+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"51517e2959a0e03076b7cb0424edf71e1e786927","claim":"ANGIODYNAMICS INC shareholders approved Election of Class II directors at the 2023-11-14 meeting.","evidence_excerpt":"1. The nominees for election to the Board of Directors of AngioDynamics were elected, each as a Class II director to serve until the 2026 Annual Meeting of Shareholders of AngioDynamics and until their respective successors are duly elected and qualified, based upon the following votes: Nominee Votes For Withheld Broker Non-Votes Eileen O. Auen 23,553,074 3,039,968 5,784,837 James C. Clemmer 25,883,397 709,645 5,784,837 Howard W. Donnelly 24,605,006 1,988,036 5,784,837 Jan Stern Reed 24,900,465 1,692,577 5,784,837","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-14"}],"fact_type":"shareholder_vote"},{"claim_id":"6b3db92b4964d8befc76c0a289d1ca8c3ca27778","claim":"ANGIODYNAMICS INC shareholders approved Advisory approval of executive compensation (Say On Pay) at the 2023-11-14 meeting.","evidence_excerpt":"3. The proposal to approve, on an advisory basis, AngioDynamics’ executive compensation of its named executive officers (“Say On Pay”) was approved based upon the following votes: Votes for approval 24,393,365 Votes against 2,193,446 Abstentions 6,231 Broker non-votes 5,784,837","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-14"}],"fact_type":"shareholder_vote"},{"claim_id":"96327bc3b4f30cc8049c6dc17a5ad8d6230994c5","claim":"ANGIODYNAMICS INC shareholders approved Approve amendments to the AngioDynamics, Inc. 2020 Equity Incentive Plan at the 2023-11-14 meeting.","evidence_excerpt":"4. The proposal to approve amendments to the AngioDynamics, Inc. 2020 Equity Incentive Plan was approved based upon the following votes: Votes for approval 24,111,357 Votes against 2,461,478 Abstentions 20,207 Broker non-votes 5,784,837","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-14"}],"fact_type":"shareholder_vote"},{"claim_id":"d4c27cbe74884ad4dcdf6e1c50d71285acc9b8e2","claim":"ANGIODYNAMICS INC shareholders approved Advisory vote on frequency of Say On Pay vote at the 2023-11-14 meeting.","evidence_excerpt":"5. The proposal to approve, on an advisory basis the frequency of the Say On Pay vote was approved to take place annually based upon the following votes: Votes for 1 year 24,882,516 Votes for 2 years 5,024 Votes for 3 years 1,696,442 Abstentions 9,060 Broker non-votes 5,784,837","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-14"}],"fact_type":"shareholder_vote"},{"claim_id":"d5f06ec77643aa1c3afadbe12b41293717fa2832","claim":"ANGIODYNAMICS INC shareholders approved Ratify appointment of Deloitte & Touche LLP as independent registered public accounting firm at the 2023-11-14 meeting.","evidence_excerpt":"2. The proposal to ratify the appointment of Deloitte & Touche LLP as AngioDynamics’ independent registered public accounting firm for the fiscal year ending May 31, 2024 was approved based upon the following votes: Votes for approval 32,364,352 Votes against 11,237 Abstentions 2,290 There were no broker non-votes for this item.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123053522/0001140361-23-053522-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}